A Review on Computer-Aided Chemogenomics and Drug Repositioning for Rational COVID-19 Drug Discovery

    August 2022 in “ Chemical Biology & Drug Design ”
    Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh … Navid Rabiee
    Studysummary This review outlines computational strategies, including chemogenomics and drug repositioning, for coronavirus drug discovery and reports no new clinical findings; the authors highlight the advantages of these methods in rapidly identifying therapeutic candidates.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. A Review on Computer-Aided Chemogenomics and Drug Repositioning for Rational COVID-19 Drug Discovery Chemical Biology & Drug Design · 2022
    2. Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak Viruses · 2020
    3. Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19 Pharmacological Reports · 2020
    4. Exploring the New Horizons of Drug Repurposing: A Vital Tool for Turning Hard Work into Smart Work European Journal of Medicinal Chemistry · 2019